Correlation Between Genelux Common and Clearmind Medicine

Can any of the company-specific risk be diversified away by investing in both Genelux Common and Clearmind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Clearmind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genelux Common and Clearmind Medicine Common, you can compare the effects of market volatilities on Genelux Common and Clearmind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Clearmind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Clearmind Medicine.

Diversification Opportunities for Genelux Common and Clearmind Medicine

0.13

Correlation Coefficient

Genelux Common  Clearmind Medicine

Average diversification

The 3 months correlation between Genelux and Clearmind is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Clearmind Medicine Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearmind Medicine Common and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Clearmind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearmind Medicine Common has no effect on the direction of Genelux Common i.e., Genelux Common and Clearmind Medicine go up and down completely randomly.

Pair Corralation between Genelux Common and Clearmind Medicine

Given the investment horizon of 90 days Genelux Common is expected to generate 0.84 times more return on investment than Clearmind Medicine. However, Genelux Common is 1.19 times less risky than Clearmind Medicine. It trades about 0.09 of its potential returns per unit of risk. Clearmind Medicine Common is currently generating about 0.03 per unit of risk. If you would invest  255.00  in Genelux Common on October 25, 2024 and sell it today you would earn a total of  60.00  from holding Genelux Common or generate 23.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Genelux Common  vs.  Clearmind Medicine Common

Genelux Common

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common showed solid returns over the last few months and may actually be approaching a breakup point.

Clearmind Medicine Common

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearmind Medicine may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Genelux Common and Clearmind Medicine

The main advantage of trading using opposite Genelux Common and Clearmind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Clearmind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearmind Medicine will offset losses from the drop in Clearmind Medicine's long position.

The idea behind Genelux Common and Clearmind Medicine Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.